Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06575075
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
Pilot Study of RR-HNK in OCD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Double-blind Placebo-controlled Study to Determine the Safety and Feasibility of Two Doses of Intravenous 2R 6R-Hydroxynorketamine RR-HNK in Adults With Obsessive-Compulsive Disorder
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HNKO
Brief Summary:
The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms
Detailed Description:
This protocol examines the safety and efficacy of 2 dosage levels of intravenous RR-HNK administration in individuals with OCD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None